Gossamer Bio (GOSS) EV to CFO (2019 - 2026)
Gossamer Bio (GOSS) posted EV to CFO of 0.15 for Q2 2026, down 73.72% on a QoQ basis from 0.56 in Q1 2026, and up 110.42% year-over-year from 0.07 in Q2 2025.
Analysis
Gossamer Bio (GOSS) EV to CFO (2019 - 2026) Analysis & Trends
Gossamer Bio has reported EV to CFO for 8 years, with the latest figure at 0.15 in Q2 2026.
- On a quarterly basis, EV to CFO rose 110.42% year-over-year to 0.15 in Q2 2026; TTM through Jun 2026 was 0.04, a 108.29% increase from a year earlier, with the FY2025 full-year figure at 3.43, down 113.13% from the prior year.
- EV to CFO was 0.15 for Q2 2026 at Gossamer Bio, down from 0.56 in the prior quarter.
- The five-year high for EV to CFO was 4.71 in Q4 2023, with the low at 22.18 in Q3 2022.
- Average EV to CFO over 5 years is 2.55, with a median of 0.17 recorded in 2025.
- The sharpest annual moves came in 2023 and 2025: EV to CFO jumped 343.03% in 2023, then slumped 576.32% in 2025.
- Over 5 years, EV to CFO stood at 1.06 in 2022, then surged by 343.03% to 4.71 in 2023, then sank by 45.84% to 2.55 in 2024, then plunged by 576.32% to 12.16 in 2025, then soared by 101.21% to 0.15 in 2026.
- The last three EV to CFO figures came in at 0.15 (Q2 2026), 0.56 (Q1 2026), and 12.16 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Gossamer Bio | 51.23 Mn | -5.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.15 |
| Mar 31, 2026 | 0.56 |
| Dec 31, 2025 | -12.16 |
| Sep 30, 2025 | -11.84 |
| Jun 30, 2025 | -1.42 |
| Mar 31, 2025 | 0.20 |
| Dec 31, 2024 | 2.55 |
| Sep 30, 2024 | 3.21 |
| Jun 30, 2024 | -1.30 |
| Mar 31, 2024 | -0.43 |
| Dec 31, 2023 | 4.71 |
| Sep 30, 2023 | 4.11 |
| Jun 30, 2023 | 1.24 |
| Mar 31, 2023 | 1.54 |
| Dec 31, 2022 | 1.06 |
| Sep 30, 2022 | -22.18 |
| Jun 30, 2022 | -8.61 |
| Mar 31, 2022 | -7.35 |
| Dec 31, 2021 | -13.12 |
| Sep 30, 2021 | -13.81 |